BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 7986144)

  • 1. Detection of submicroscopic lymph node metastases with polymerase chain reaction in patients with malignant melanoma.
    Wang X; Heller R; VanVoorhis N; Cruse CW; Glass F; Fenske N; Berman C; Leo-Messina J; Rappaport D; Wells K
    Ann Surg; 1994 Dec; 220(6):768-74. PubMed ID: 7986144
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lymph node micrometastases of cutaneous melanoma: increased sensitivity of molecular diagnosis in comparison to immunohistochemistry.
    Blaheta HJ; Schittek B; Breuninger H; Maczey E; Kroeber S; Sotlar K; Ellwanger U; Thelen MH; Rassner G; Bültmann B; Garbe C
    Int J Cancer; 1998 Aug; 79(4):318-23. PubMed ID: 9699521
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular staging of malignant melanoma: correlation with clinical outcome.
    Shivers SC; Wang X; Li W; Joseph E; Messina J; Glass LF; DeConti R; Cruse CW; Berman C; Fenske NA; Lyman GH; Reintgen DS
    JAMA; 1998 Oct; 280(16):1410-5. PubMed ID: 9801000
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sentinel lymph node: detection of micrometastases of melanoma in a molecular study.
    Denninghoff VC; Kahn AG; Falco J; Curutchet HP; Elsner B
    Mol Diagn; 2004; 8(4):253-8. PubMed ID: 15887981
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of tyrosinase mRNA by reverse transcription-polymerase chain reaction in melanoma sentinel nodes.
    Bieligk SC; Ghossein R; Bhattacharya S; Coit DG
    Ann Surg Oncol; 1999; 6(3):232-40. PubMed ID: 10340881
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of occult breast cancer micrometastases in axillary lymph nodes using a multimarker reverse transcriptase-polymerase chain reaction panel.
    Lockett MA; Baron PL; O'Brien PH; Elliott BM; Robison JG; Maitre N; Metcalf JS; Cole DJ
    J Am Coll Surg; 1998 Jul; 187(1):9-16. PubMed ID: 9660019
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular test for the detection of tumor cells in blood and sentinel nodes of melanoma patients.
    Van der Velde-Zimmermann D; Roijers JF; Bouwens-Rombouts A; De Weger RA; De Graaf PW; Tilanus MG; Van den Tweel JG
    Am J Pathol; 1996 Sep; 149(3):759-64. PubMed ID: 8780380
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The sentinel lymph node in melanoma: utilization of molecular biology (RT-PCR) to detect occult metastases].
    Riccioni L; Farabegoli P; Nanni O; Morigi F; Polverelli M; Landi G; Giangaspero F
    Pathologica; 2002 Aug; 94(4):190-5. PubMed ID: 12325417
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Examination of regional lymph nodes by sentinel node biopsy and molecular analysis provides new staging facilities in primary cutaneous melanoma.
    Blaheta HJ; Ellwanger U; Schittek B; Sotlar K; MacZey E; Breuninger H; Thelen MH; Bueltmann B; Rassner G; Garbe C
    J Invest Dermatol; 2000 Apr; 114(4):637-42. PubMed ID: 10733666
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular analysis in evaluating the sentinel node in malignant melanoma.
    Sung J; Li W; Shivers S; Reintgen D
    Ann Surg Oncol; 2001 Oct; 8(9 Suppl):29S-30S. PubMed ID: 11599893
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mapping of occult melanoma micrometastases in the inguinal lymph node basin by immunohistochemistry and RT-PCR.
    Hatta N; Fujimoto A; Takehara K; Takata M
    Melanoma Res; 1999 Aug; 9(4):401-6. PubMed ID: 10504060
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of melanoma micrometastases in the sentinel lymph node and in nonsentinel nodes by tyrosinase polymerase chain reaction.
    Lukowsky A; Bellmann B; Ringk A; Winter H; Audring H; Fenske S; Sterry W
    J Invest Dermatol; 1999 Oct; 113(4):554-9. PubMed ID: 10504440
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peripheral blood tyrosinase messenger RNA detection and survival in malignant melanoma.
    Kunter U; Buer J; Probst M; Duensing S; Dallmann I; Grosse J; Kirchner H; Schluepen EM; Volkenandt M; Ganser A; Atzpodien J
    J Natl Cancer Inst; 1996 May; 88(9):590-4. PubMed ID: 8609659
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serial follow-up and the prognostic significance of reverse transcriptase-polymerase chain reaction--staged sentinel lymph nodes from melanoma patients.
    Kammula US; Ghossein R; Bhattacharya S; Coit DG
    J Clin Oncol; 2004 Oct; 22(19):3989-96. PubMed ID: 15459222
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optimal detection of sentinel lymph node metastases by intraoperative radioactive threshold and molecular analysis in patients with melanoma.
    Manca G; Romanini A; Pellegrino D; Borsò E; Rondini M; Orlandini C; Zucchi V; Pasqualetti F; Mariani G
    J Nucl Med; 2008 Nov; 49(11):1769-75. PubMed ID: 18927334
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polymerase chain reaction and immunohistochemistry frequently detect occult melanoma cells in regional lymph nodes of melanoma patients.
    Hatta N; Takata M; Takehara K; Ohara K
    J Clin Pathol; 1998 Aug; 51(8):597-601. PubMed ID: 9828818
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Accurate molecular detection of melanoma nodal metastases: an assessment of multimarker assay specificity, sensitivity, and detection rate.
    Davids V; Kidson SH; Hanekom GS
    Mol Pathol; 2003 Feb; 56(1):43-51. PubMed ID: 12560463
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular and biochemical testing in stage III melanoma: multimarker reverse transcriptase-polymerase chain reaction assay of lymph fluid after lymph node dissection and preoperative serum lactate dehydrogenase level.
    Nowecki ZI; Rutkowski P; Kulik J; Siedlecki JA; Ruka W
    Br J Dermatol; 2008 Sep; 159(3):597-605. PubMed ID: 18616789
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic significance of occult metastases detected by sentinel lymphadenectomy and reverse transcriptase-polymerase chain reaction in early-stage melanoma patients.
    Bostick PJ; Morton DL; Turner RR; Huynh KT; Wang HJ; Elashoff R; Essner R; Hoon DS
    J Clin Oncol; 1999 Oct; 17(10):3238-44. PubMed ID: 10506625
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pathologic assessment of melanoma sentinel nodes: a role for molecular analysis using quantitative real-time reverse transcription-PCR for MART-1 and tyrosinase messenger RNA.
    Abrahamsen HN; Sorensen BS; Nexo E; Hamilton-Dutoit SJ; Larsen J; Steiniche T
    Clin Cancer Res; 2005 Feb; 11(4):1425-33. PubMed ID: 15746042
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.